Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001)-Reference-Cited by-同舟云学术

Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001)

Published:2024-02-19 Issue:6 Volume:93 Page:565-573
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Ozawa Mayumi,Watanabe Jun^ORCID,Ishibe Atsushi,Goto Koki,Fujii Yoshiro,Nakagawa Kazuya,Suwa Yusuke,Suwa Hirokazu,Masui Hidenobu,Sugita Mitsutaka,Mochizuki Yasuhisa,Yamagishi Shigeru,Hasegawa Seiji,Homma Yuki,Momiyama Masashi,Kumamoto Takafumi,Matsuyama Ryusei,Takeda Kazuhisa,Taguri Masataka,Endo Itaru

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00280-024-04648-6.pdf

Reference24 articles.

1. Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

2. AlBandar MH, Kim NK (2017) Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review). Oncol Rep 37(5):2553–2564

3. Hackl C et al (2014) Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer 14:810

4. Altendorf-Hofmann A, Scheele J (2003) A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 12(1):165–192

5. Lintoiu-Ursut B, Tulin A, Constantinoiu S (2015) Recurrence after hepatic resection in colorectal cancer liver metastasis -review article. J Med Life 8(Spec Issue):12–14